Accession Number: | 0001209191-19-061950 |
Date: | 2019-12-23 |
Issuer: | ADVERUM BIOTECHNOLOGIES, INC. (ADVM) |
Original Submission Date: |
PATTERSON LEONE D
C/O ADVERUM BIOTECHNOLOGIES, INC.
1035 O'BRIEN DRIVE
MENLO PARK, CA 94025
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-23 | S | 40,000 | d | $10.72 | 228,496 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this transaction was pursuant to a 10b5-1 plan. |
f2 | represents weighted average sales price. the shares were sold at prices ranging from $10.30 to $11.055. the reporting person will provide upon request, to the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |